Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

1,189

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

May 1, 2020

Study Completion Date

December 31, 2021

Conditions
Intravenous Alteplase ThrombolysisNeurological Improving
Interventions
DRUG

ginkgolide

ginkgolide plus alteplase

Trial Locations (1)

310000

Min Lou, Hangzhou

All Listed Sponsors
collaborator

Dongyang People's Hospital

OTHER

collaborator

Haiyan People's Hospital

UNKNOWN

collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

collaborator

Tongxiang Second People's Hospital

UNKNOWN

collaborator

Tongxiang First People's Hospital

UNKNOWN

collaborator

Changxing People's Hospital

OTHER

collaborator

The Central Hospital of Lishui City

OTHER

collaborator

The First People's Hospital of Huzhou

OTHER

collaborator

Taizhou First People's Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT03772847 - Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial | Biotech Hunter | Biotech Hunter